Home/Filings/4/0001209191-21-033362
4//SEC Filing

Chowdhury Badrul A. 4

Accession 0001209191-21-033362

CIK 0001160308other

Filed

May 16, 8:00 PM ET

Accepted

May 17, 9:57 PM ET

Size

9.5 KB

Accession

0001209191-21-033362

Insider Transaction Report

Form 4
Period: 2021-05-15
Chowdhury Badrul A.
Chief Medical Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2021-05-15+200,000200,000 total
  • Exercise/Conversion

    Restricted Stock Units

    2021-05-15200,0000 total
    Exercise: $0.00Common Stock (200,000 underlying)
  • Sale

    Common Stock

    2021-05-17$1.56/sh50,000$77,870150,000 total
Footnotes (3)
  • [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 23, 2020 in order to satisfy tax withholding obligations in connection with the vesting of restricted stock units on May 15, 2021.
  • [F2]The price is a weighted average sale price. The sale prices ranged from $1.50 to $1.61. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
  • [F3]The restricted stock units vested in full on May 15, 2021.

Issuer

Savara Inc

CIK 0001160308

Entity typeother

Related Parties

1
  • filerCIK 0001776662

Filing Metadata

Form type
4
Filed
May 16, 8:00 PM ET
Accepted
May 17, 9:57 PM ET
Size
9.5 KB